Brief: FDA Identified Getinge's Recall Of Vaporizer Sevoflurane Maquet Filling As Class I Recall
June 13 (Reuters) - Getinge AB GETIb.ST :
* FDA:GETINGE RECALLS VAPORIZER SEVOFLURANE MAQUET FILLING
FOR
RISK OF PATIENT AND HEALTH CARE PROFESSIONAL EXPOSURE TO TOXIC
CHEMICAL HYDROGEN FLUORIDE
* FDA: IDENTIFIED GETINGE'S RECALL OF VAPORIZER SEVOFLURANE
MAQUET
FILLING AS CLASS I RECALL
Further company coverage: GETIb.ST
((reuters.briefs@thomsonreuters.com;))
Recent news on Getinge publ AB
See all newsEurope Research Roundup: Akzo Nobel, Handelsbanken, RS Group
Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix (updated)
Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix
Sweden's Getinge Q3 organic sales rise 2.1%
Brief: Getinge Q3 Adjusted EBITA SEK 1,278 Million